Journal of Neural Transmission

Article	Citations
Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Ried	47
Recent update on the heterogeneity of the Alzheimer’s disease spectrum	44
Dystonia updates: definition, nomenclature, clinical classification, and etiology	40
Effects of safinamide on pain in Parkinson’s disease with motor fluctuations: an exploratory study	39
Impact of the COVID-19 lockdown on screen media use in patients referred for ADHD to child and adolescent psychiatry: an introduction to problematic use of the internet in ADHD and results of a survey	38
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity	36
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease	36
Neuropathological assessment of the Alzheimer spectrum	35
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials	34
Contemporary functional neuroanatomy and pathophysiology of dystonia	34
Do not keep it simple: recent advances in the generation of complex organoids	32
Emerging and converging molecular mechanisms in dystonia	29
Neuronal intranuclear inclusion disease: recognition and update	29
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration	27
A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease	26
Iron and inflammation: in vivo and post-mortem studies in Parkinson’s disease	26
Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis	25
ADHD at the workplace: ADHD symptoms, diagnostic status, and work-related functioning	25
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice	24
Viruses, parkinsonism and Parkinson’s disease: the past, present and future	23
A brief history of brain iron accumulation in Parkinson disease and related disorders	23
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia	22
Hypothyroidism after radiation exposure: brief narrative review	22
COVID-19 outcomes of 10,881 patients: retrospective study of neurological symptoms and associated manifestations (Philippine CORONA Study)	22
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t	22

GBA-associated PD: chances and obstacles for targeted treatment strategies	22
Language in autism: domains, profiles and co-occurring conditions	21
Glucocerebrosidase mutations and Parkinson disease	21
Chorea in children: etiology, diagnostic approach and management	20
Mental health dished up—the use of iPSC models in neuropsychiatric research	20
Improvement of brain functional connectivity in autism spectrum disorder: an exploratory study on the potential use of virtual reality	20
Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan	19
Morphological basis of Parkinson disease-associated cognitive impairment: an update	19
Feigning ADHD and stimulant misuse among Dutch university students	19
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease	19
Metacognition in adult ADHD: subjective and objective perspectives on self-awareness of cognitive functioning	19
Neurorehabilitation in dystonia: a holistic perspective	19
Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson’s disease: mutational spectrum and clinical features	19
Safinamide improves executive functions in fluctuating Parkinson’s disease patients: an exploratory study	19
Neuropsychological functioning of individuals at clinical evaluation of adult ADHD	19
Parkinson and depression: review and outlook	19
Genes and hormones of the hypothalamic–pituitary–adrenal axis in post-traumatic stress disorder. What is their role in symptom expression and treatment response?	18
From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview	18
Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson’s disease	18
Cerebral white matter changes in deficit and non-deficit subtypes of schizophrenia	18
Neurodegenerative proteinopathies associated with neuroinfections	18
Isolated dystonia: clinical and genetic updates	17
SIRT1 and SIRT2 modulators reduce LPS-induced inflammation in HAPI microglial cells and protect SH-SY5Y neuronal cells in vitro	17
Cognitive characterization of adult attention deficit hyperactivity disorder by domains: a systematic review	17
Autoimmune encephalitis with psychiatric features in adults: historical evolution and prospective challenge	17
Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis	17
The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models	17
Recent trends in mental illness and omega-3 fatty acids	16
The cerebral blood flow deficits in Parkinson’s disease with mild cognitive impairment using arterial spin labeling MRI	16
The pathobiological basis of depression in Parkinson disease: challenges and outlooks	15
Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis	15
The MPTP-lesioned marmoset model of Parkinson’s disease: proposed efficacy thresholds that may potentially predict successful clinical trial results	15
Protein clearance strategies for disease intervention	14
Emergent creativity in frontotemporal dementia	14
Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses	14
Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease	14
Prevalence and sort of pharmacokinetic drug–drug interactions in hospitalized psychiatric patients	14
Botulinum toxin therapy of dystonia	14
Evaluation for Parkinsonian Bradykinesia by deep learning modeling of kinematic parameters	14
Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids	13
Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach	13
Beyond tics: movement disorders in patients with Tourette syndrome	13
Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort	13
Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network	13
Neuropathological findings in multiple system atrophy with cognitive impairment	13
Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases	13
The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease	13
Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors	13
The heterogeneity of Parkinson’s disease	13
Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias	13

ADHD and offending	12
Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients	12
Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors	12
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort	12
Hemispheric asymmetries in mental disorders: evidence from rodent studies	12
Comparison of the rate of dedifferentiation with increasing passages among cell sources for an in vitro model of the blood–brain barrier	12
Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders	12
Combined dystonias: clinical and genetic updates	12
Interleukin-6 secretion upon acute psychosocial stress as a potential predictor of psychotherapy outcome in posttraumatic stress disorder	11
Long-term effects of chronic stress models in adult mice	11
Effects of head trauma and sport participation in young-onset Parkinson’s disease	11
Resident CD34-positive cells contribute to peri-endothelial cells and vascular morphogenesis in salivary gland after irradiation	11
Transcranial random noise stimulation over the primary motor cortex in PD-MCI patients: a crossover, randomized, sham-controlled study	11
Is the vertex a good control stimulation site? Theta burst stimulation in healthy controls	11
Complex dystonias: an update on diagnosis and care	11
Current experimental disease-modifying therapeutics for multiple system atrophy	11
Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia	11
Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS)	11
Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress	11
Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update	11
Autism Spectrum Disorder and auditory sensory alterations: a systematic review on the integrity of cognitive and neuronal functions related to auditory processing	11
Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson’s disease	11
Life style and Parkinson’s disease	10
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment	10
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles	10
Normal pressure hydrocephalus and CSF tap test response: the gait phenotype matters	10
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey	10
Anxiety, depression and psychosocial needs are the most frequent concerns reported by patients: preliminary results of a comparative explorative analysis of two hospital-based palliative care teams in	10
Stress and pain: modality-specific opioid mediation of stress-induced analgesia	10
Internet-based cognitive behavioral therapy in children and adolescents with obsessive compulsive disorder: a feasibility study	10
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor	10
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes	10
Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset	10
Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson’s disease in the MARK-PD study	10
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease	10
Synaptic plasticity mechanisms behind TMS efficacy: insights from its application to animal models	10
Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease	10
Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017	10
Non-credible symptom report in the clinical evaluation of adult ADHD: development and initial validation of a new validity index embedded in the Conners’ adult ADHD rating scales	9
α7 nicotinic receptors contributes to glutamatergic activity in the hippocampus of patients with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS)	9
Voxel-based lesion symptom mapping analysis for dysphagia in stroke patients with isolated cerebellar lesions	9
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes	9
Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors	9
Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue	9
Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients	9
Botulinum toxin therapy: past, present and future developments	9
Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study	9
Associations of age, sex, sexual abuse, and genotype with monoamine oxidase a gene methylation	9
Gaze behavior is associated with the cortisol response to acute psychosocial stress in the virtual TSST	9
The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19	9
Implications of dopaminergic medication withdrawal in Parkinson’s disease	9
Essential tremor plus rest tremor: current concepts and controversies	9
Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly	9
Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson’s disease	9
Bioinformatics approach reveals the critical role of the NOD-like receptor signaling pathway in COVID-19-associated multiple sclerosis syndrome	9
Tau proteins in blood as biomarkers of Alzheimer’s disease and other proteinopathies	9
Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer’s disease	9
C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy	9
The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder	9
NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity	9
Blood neurofilament light chain in Parkinson’s disease	9
A historical review of multiple system atrophy with a critical appraisal of cellular and animal models	8
Suboptimal response to STN-DBS in Parkinson’s disease can be identified via reaction times in a motor cognitive paradigm	8
Associations between age and cortisol awakening response in patients with borderline personality disorder	8
Genetic updates on paroxysmal dyskinesias	8
Association of early and later depressive symptoms with functional outcome after ischemic stroke	8
Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients	8
Depression in dementia with Lewy bodies: a critical update	8
Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits	8
Autophagy in trimethyltin-induced neurodegeneration	8
X-linked dystonia Parkinsonism: crossing a new threshold	8
Small intestinal bacterial overgrowth in Alzheimer’s disease	7
Impact of the COVID-19 pandemic on mental health and family situation of clinically referred children and adolescents in Switzerland: results of a survey among mental health care professionals after 1	7
The use of wearables for the diagnosis and treatment of Parkinson’s disease	7
Assessment and treatment of substance use in adults with ADHD: a psychological approach	7
Oscillatory activity in the BNST/ALIC and the frontal cortex in OCD: acute effects of DBS	7
Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down?	7
Disease modification in Parkinsonism: obstacles and ways forward	7
Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study	7
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone	7

Genome-wide methylation association with current suicidal ideation in schizophrenia	7
Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy	7
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson’s disease	7
Dystonia and leveraging oral pharmacotherapy	7
Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study	7
Evidence supporting the role of telomerase, MMP-9, and SIRT1 in attention-deficit/hyperactivity disorder (ADHD)	7
New modalities and directions for dystonia care	7
Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?	7
Insights into Lewy body disease from rare neurometabolic disorders	7
The enigma of vascular depression in old age: a critical update	7
Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis	7
The impact of maternal care and blood glucose availability on the cortisol stress response in fasted women	7
Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression	6
Dual task gait deteriorates gait performance in cervical dystonia patients: a pilot study	6
Autoantibody-associated psychiatric syndromes in children: link to adult psychiatry	6
Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations	6
GenIDA: an international participatory database to gain knowledge on health issues related to genetic forms of neurodevelopmental disorders	6
Betrayed by the nervous system: a comparison group study to investigate the ‘unsafe world’ model of selective mutism	6
Iron and copper ions accelerate and modify dopamine oxidation to eumelanin: implications for neuromelanin genesis	6
The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin	6
Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder	6
Impact of early intervention with onabotulinumtoxinA treatment in adult patients with post-stroke lower limb spasticity: results from the double-blind, placebo-controlled, phase 3 REFLEX study	6
DNA hypomethylation of the Krüppel-like factor 11 (KLF11) gene promoter: a putative biomarker of depression comorbidity in panic disorder and of non-anxious depression?	6
Serum NfL and CHI3L1 for ALS and parkinsonian disorders in the process of diagnosis	6
Endothelial nitric oxide synthase (NOS3) rs2070744 polymorphism and risk for multiple sclerosis	6
Tryptophan modulation in individuals with attention deficit hyperactivity disorder: a systematic review	6
A sudden and severe depressive episode after a left cingulate gyrus stroke: a case report of post-stroke depression and review of literature	6
Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations	6
Arching deep brain stimulation in dystonia types	6
Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt–Jakob disease in clinical practice	6
Cognition, motor symptoms, and glycolipid metabolism in Parkinson’s disease with depressive symptoms	6
Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels	6
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study	6
Patients with higher vitamin D levels show stronger improvement of self-reported depressive symptoms in psychogeriatric day-care setting	6
Efficacy of adjunctive d-Cycloserine for the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials	6
Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient care	6
The importance of genetic testing for dystonia patients and translational research	6
Public perceptions of adult ADHD: Indications of stigma?	6
Genetic and epigenetic analyses of panic disorder in the post-GWAS era	6
Abnormal cerebellum connectivity patterns related to motor subtypes of Parkinson’s disease	5
Caregiver burden in patients with behavioural variant frontotemporal dementia and non-fluent variant and semantic variant primary progressive aphasia	5
Issues for patchy tissues: defining roles for gut-associated lymphoid tissue in neurodevelopment and disease	5
The role of stress coping strategies for life impairments in ADHD	5
Differential spatial distribution of white matter lesions in Parkinson’s and Alzheimer’s diseases and cognitive sequelae	5
Genetic testing for Parkinson’s disease in clinical practice	5
Changes in the TMS-evoked potential N100 in the dorsolateral prefrontal cortex as a function of depression severity in adolescents	5
Influence of stress on physiological synchrony in a stressful versus non-stressful group setting	5
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review	5
COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study	5
Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug	5
Sex differences in schizophrenia: a longitudinal methylome analysis	5
Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage	5
Effects of systemic glycine on accumbal glycine and dopamine levels and ethanol intake in male Wistar rats	5
Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease	5
REM sleep absence in patients referred to polysomnography for REM sleep behavior disorder	5
Diagnostic value of micrographia in Parkinson’s disease: a study with [123I]FP-CIT SPECT	5
Association between heart rate variability and striatal dopamine depletion in Parkinson’s disease	5
Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters	5
Effects of agmatine, glutamate, arginine, and nitric oxide on executive functions in children with attention deficit hyperactivity disorder	5
Hyposmia may predict development of freezing of gait in Parkinson’s disease	5
Resting-state network connectivity changes in drug-naive Parkinson’s disease patients with probable REM sleep behavior disorder	5
Remdesivir shifts circadian rhythmicity to eveningness; similar to the most prevalent chronotype in ADHD	5
Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity	5
Gastrointestinal mucosal biopsies in Parkinson’s disease: beyond alpha-synuclein detection	5
Covariation of psychobiological stress regulation with valence and quantity of social interactions in everyday life: disentangling intra- and interindividual sources of variation	5
Neurocognitive profile of patients with X-linked dystonia-parkinsonism	5
Effects of intrathecal baclofen therapy in subjects with disorders of consciousness: a reappraisal	5
Fluid markers of synapse degeneration in synucleinopathies	4
The association of the 5-HTTLPR polymorphism and the response to different stressors in healthy males	4
Plasma concentrations of anti-inflammatory cytokine TGF-β are associated with hippocampal structure related to explicit memory performance in older adults	4
Diagnostic accuracy of glabellar tap sign for Parkinson’s disease	4
Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease	4
Tractography patterns of pedunculopontine nucleus deep brain stimulation	4
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder	4
ADHD and associated psychopathology in older adults in a German community sample	4
Three-way interaction effects of early life stress, positive parenting and FKBP5 in the development of depressive symptoms in a general population	4
Neurophysiological investigation of auditory intensity dependence in patients with Parkinson’s disease	4
Contemporary clinical neurophysiology applications in dystonia	4
Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuries	4
Proteinopathies associated to repeat expansion disorders	4
Ultrastructural characterization of peripheral denervation in a mouse model of Type III spinal muscular atrophy	4
Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study	4
Cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy (MT); comparison of three established psychotherapies and possible common neural mechanisms of psychothe	4
More focal, less heterogeneous? Multi-level meta-analysis of cathodal high-definition transcranial direct current stimulation effects on language and cognition	4
Reduced vagal activity in borderline personality disorder is unaffected by intranasal oxytocin administration, but predicted by the interaction between childhood trauma and attachment insecurity	4
Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson’s disease	4
Polymorphisms of COMT and CREB1 are associated with treatment-resistant depression in a Chinese Han population	4
Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease	4
Genetic and environmental mouse models of autism reproduce the spectrum of the disease	4
Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?	4
Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study	4
Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism	4
Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview	4
The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors	4
The language profile in multiple system atrophy: an exploratory study	4